Healthcare -
Biotechnology - NASDAQ - US
$ 11.1
0.892 %
$ 161 M
Market Cap
0.11
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Inhibrx Biosciences, Inc.
| Net Income | 1.69 B |
| Depreciation & Amortization | 2.28 M |
| Capital Expenditures | -2.6 M |
| Stock-Based Compensation | 58.5 M |
| Change in Working Capital | 52.1 M |
| Others | -1.96 B |
| Free Cash Flow | -197 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | 1 687.6 | (239.7) | (145.2) | (81.8) | (76.1) | (51.4) | (31.0) | (22.1) | (8.3) |
| Depreciation & Amortization | 2.3 | 1.2 | 1.2 | 1.2 | 1.0 | 1.2 | 0.7 | 0.4 | 0.3 |
| Deferred Income Tax | 0 | 0 | 0 | 9 K | (2.1) | 1.1 | 0 | 0 | 0 |
| Stock Based Compensation | 58.5 | 24.8 | 17.8 | 15.0 | 5.0 | 4.0 | 2.5 | 1.2 | 0.6 |
| Other Operating Activities | (1 994.8) | 5.0 | 5.1 | 2.7 | 11.6 | 9.6 | 0.5 | 0.7 | (3.4) |
| Change in Working Capital | 52.1 | 15.3 | 3.2 | (17.5) | 12.7 | 3.5 | 4.2 | 1.0 | (6.3) |
| Cash From Operations | (194.4) | (193.3) | (115.3) | (80.3) | (48.0) | (32.1) | (23.1) | (18.8) | (18.1) |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | (2.6) | (4.6) | (0.7) | (0.9) | (1.4) | (1.8) | (1.4) | (1.3) | (0.2) |
| Other Items | 0 | 0 | 0 | 55 K | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | (2.6) | (4.6) | (0.7) | (0.8) | (1.4) | (1.8) | (1.4) | (1.3) | (0.2) |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | (0.8) | (1.4) | 0 |
| Other Financing Activities | 71.7 | 202.0 | 128.8 | 83.8 | 166.5 | 43.3 | 14.0 | 14.9 | 28.8 |
| Cash From Financing Activities | 71.7 | 202.0 | 258.6 | 83.8 | 166.5 | 43.3 | 13.2 | 13.5 | 28.8 |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | (125.3) | 4.1 | 142.6 | 2.6 | 117.1 | 9.4 | (11.4) | (6.6) | 10.4 |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | (197.0) | (197.9) | (116.0) | (81.2) | (49.3) | (33.9) | (24.5) | (20.1) | (18.3) |